Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work.
about
Eclectic Ocular Comorbidities and Systemic Diseases with Eye Involvement: A ReviewComorbidity polypharmacy score and its clinical utility: A pragmatic practitioner's perspectiveDevelopment of a tool for defining and identifying the dying patient in hospital: Criteria for Screening and Triaging to Appropriate aLternative care (CriSTAL)Charlson index scores from administrative data and case-note review compared favourably in a renal disease cohort.Mortality Risk Prediction: Can Comorbidity Indices Be Improved With Psychosocial Data?Management of asthma and chronic obstructive pulmonary disease with combination inhaled corticosteroids and long-acting β-agonists: a review of comparative effectiveness research.Charlson comorbidity index derived from chart review or administrative data: agreement and prediction of mortality in intensive care patientsUsing self-reported health measures to predict high-need cases among Medicaid-eligible adults.Incidental pancreatic cystic lesions: is there a relationship with the development of pancreatic adenocarcinoma and all-cause mortality?Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010.Higher Preoperative Patient Activation Associated With Better Patient-reported Outcomes After Total Joint Arthroplasty.A Simple Method for Evaluating Within Sample Prognostic Balance Achieved by Published Comorbidity Summary MeasuresCase mix adjustment of health outcomes, resource use and process indicators in childbirth care: a register-based study.The Deyo-Charlson and Elixhauser-van Walraven Comorbidity Indices as predictors of mortality in critically ill patients.Effects of longitudinal changes in Charlson comorbidity on prognostic survival model performance among newly diagnosed patients with hypertensionComparison of Comorbidity Scores in Predicting Surgical Outcomes.A new Elixhauser-based comorbidity summary measure to predict in-hospital mortality.Healthcare Costs and Resource Utilization in Patients with Multiple Sclerosis Relapses Treated with H.P. Acthar Gel(®)Comparison of Elixhauser and Charlson Methods for Predicting Oral Cancer Survival.Psychiatric readmissions and their association with physical comorbidity: a systematic literature review.Patient Use of Electronic Prescription Refill and Secure Messaging and Its Association With Undetectable HIV Viral Load: A Retrospective Cohort Study.Identifying Patients at Risk of High Healthcare Utilization.Long-acting Reversible Contraception Among Homeless Women Veterans With Chronic Health Conditions: A Retrospective Cohort Study.Policy Research Challenges in Comparing Care Models for Dual-Eligible Beneficiaries.Diabetes and the hospitalized patient : A cluster analytic framework for characterizing the role of sex, race and comorbidity from 2006 to 2011.Comorbidity does not predict long-term mortality after total hip arthroplasty.Place of Death of Individuals with Terminal Cancer: New Insights from Medicare Hospice Place-of-Service Codes.The Cumulative Burden of Mental, Substance Use, and General Medical Disorders and Rehospitalization and Mortality After an Injury.Multiple Chronic Conditions and Hospitalizations Among Recipients of Long-Term Services and Supports.Gender Differences in the Combined Effects of Cardiovascular Disease and Osteoarthritis on Progression to Functional Impairment in Older Mexican Americans.No-fault compensation for treatment injuries in Danish public hospitals 2006-12.Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: the Chronic Hepatitis Cohort Study (CHeCS).Implementation of the Canadian CT Head Rule and Its Association With Use of Computed Tomography Among Patients With Head Injury.Institutional charges and disparities in outpatient brain biopsies in four US States: the State Ambulatory Database (SASD).Suicidal Behavior Among Hospitalized Adults With Inflammatory Bowel Disease: A United States Nationwide Analysis.Timing and impact of decisions to adjust disease-modifying antirheumatic drug therapy for rheumatoid arthritis patients with active disease.On the Use of Summary Comorbidity Measures for Prognosis and Survival Treatment Effect Estimation.Comorbidity Status and Annual Total Medical Expenditures in U.S. Hypertensive Adults.Adapting the Elixhauser comorbidity index for cancer patients.Transcatheter or surgical aortic valve replacement in patients with advanced kidney disease: A propensity score-matched analysis.
P2860
Q26751127-FBD069EC-4FFE-4BAB-88F2-151461D17531Q26775957-2F7C32C7-6AC1-4B6E-99C3-EED256B46F1AQ27693322-DE260A71-1E62-4DA0-ACA3-2A9DFAE8897BQ30884252-9E6B2A54-FBD1-42F1-92AF-5ADDB0CD8055Q30999448-FF989E1C-CEE7-46EF-B42F-836B11A84CBBQ33646667-199F90A0-015C-4AF3-89FC-A67831FA9EA9Q33812221-295ADE47-730F-413A-8D65-7DB0EA1A9009Q34559814-F4802BD4-256A-4B41-9CEC-4140519C2CC5Q35100662-D66F17F6-E8F4-45FC-A332-BF000AC15EA0Q35602372-3D0AD935-6F20-438B-80EC-6733C6AD46D1Q35807442-61EE89E7-2392-4AC7-AABC-6DAEA2DF5675Q35984076-355B00F1-CF64-4486-991E-CE601384F22DQ36035338-57E34570-4FC9-481F-8BBF-2CBF82484A11Q36038946-BC349973-8832-49DD-88D6-836BCE59505BQ36201538-801E7E5C-E272-45E5-B92B-DE52F864F83EQ36463938-ADDF1F10-07D4-42E4-9C2B-58D6CC63AFF7Q36743028-4726A91E-923E-4830-B57C-C322A2423866Q37143736-38902927-1797-4434-9402-67683FF29373Q37206254-E4093C83-4E26-4BEC-8A92-A86730ABF539Q37555950-311550D5-4636-4852-A7F7-284E4DD13312Q37675818-A2DE97B2-53A6-4737-8496-E9BBAD8EEBD2Q37676645-0CD73383-F936-4740-B8A9-C76DDABFAAF4Q38625825-594B1400-283F-48DF-AB2C-ADE99FA283E2Q38666180-6C6E3C02-2E1E-4CD3-8E10-533E1101859DQ38666240-8897144A-6A89-4340-8B32-D89B27EAE4B9Q38705243-0C85EFF7-AED1-4368-9527-AB6B306C82DCQ38930071-480234B4-7C43-4CB4-BA0A-EFEADEC1FB79Q39112137-F58F12E7-DCD2-4A7D-BA24-C8B8004ECF08Q39227899-219695D3-90A8-4F07-A519-B51F46A7F7D1Q39985254-44495476-18B9-496C-9F63-C2F34011E4C6Q40234480-E2913AAE-E47D-4AAD-831A-CB88EF47D9EFQ41746574-E86DF191-3F6B-474F-B43A-496B26814884Q43888067-EBCB2B29-FD42-452F-B142-B25CA84B2E09Q46126531-D6807B39-665D-448C-99F0-69560252B934Q47258552-EC267823-8F67-4173-91FC-B449D73CB832Q47262286-828D5A7A-FF84-4BB1-964F-771173C3DEDBQ47411646-A18B0520-03D9-4341-85FE-0338AC2D9EF2Q47447764-74BEB8E0-CA25-447D-ADA7-7462774CEA56Q48123202-117FD570-BE17-45E1-88AA-A39DAD86548DQ48252515-5F5C6333-6696-4420-83A2-8E011EBF42C1
P2860
Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Why Summary Comorbidity Measur ...... dex and Elixhauser Score Work.
@en
Why Summary Comorbidity Measur ...... dex and Elixhauser Score Work.
@nl
type
label
Why Summary Comorbidity Measur ...... dex and Elixhauser Score Work.
@en
Why Summary Comorbidity Measur ...... dex and Elixhauser Score Work.
@nl
prefLabel
Why Summary Comorbidity Measur ...... dex and Elixhauser Score Work.
@en
Why Summary Comorbidity Measur ...... dex and Elixhauser Score Work.
@nl
P2093
P2860
P1433
P1476
Why Summary Comorbidity Measur ...... ndex and Elixhauser Score Work
@en
P2093
J Robert Beck
Robert G Uzzo
Steven R Austin
Yu-Ning Wong
P2860
P304
P356
10.1097/MLR.0B013E318297429C
P577
2015-09-01T00:00:00Z